261 related articles for article (PubMed ID: 19461815)
1. Botulinum toxins for analgesia.
Smith HS
Pain Physician; 2009; 12(3):479-81. PubMed ID: 19461815
[No Abstract] [Full Text] [Related]
2. Botulinum toxin for neuropathic pain?
Apfel SC
Neurology; 2009 Apr; 72(17):1456-7. PubMed ID: 19321845
[No Abstract] [Full Text] [Related]
3. An open study of botulinum-A toxin treatment of trigeminal neuralgia.
Piovesan EJ; Teive HG; Kowacs PA; Della Coletta MV; Werneck LC; Silberstein SD
Neurology; 2005 Oct; 65(8):1306-8. PubMed ID: 16247065
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain.
Ranoux D; Attal N; Morain F; Bouhassira D
Ann Neurol; 2008 Sep; 64(3):274-83. PubMed ID: 18546285
[TBL] [Abstract][Full Text] [Related]
5. Using botulinum toxin to treat diabetic foot pain.
Kaufman JL; Karceski S
Neurology; 2009 Apr; 72(17):e82-5. PubMed ID: 19398700
[No Abstract] [Full Text] [Related]
6. An open study of botulinum-A toxin treatment of trigeminal neuralgia.
Zakrzewska JM; Cohen J; Brown J; Alksne J; Gemillion H; Linskey M; Sirois D; Pollock B
Neurology; 2006 May; 66(9):1458-9; author reply 1458-9. PubMed ID: 16685762
[No Abstract] [Full Text] [Related]
7. Botulinum toxin A does not alter capsaicin-induced pain perception in human skin.
Schulte-Mattler WJ; Opatz O; Blersch W; May A; Bigalke H; Wohlfahrt K
J Neurol Sci; 2007 Sep; 260(1-2):38-42. PubMed ID: 17481662
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial.
Yuan RY; Sheu JJ; Yu JM; Chen WT; Tseng IJ; Chang HH; Hu CJ
Neurology; 2009 Apr; 72(17):1473-8. PubMed ID: 19246421
[TBL] [Abstract][Full Text] [Related]
9. Differences in botulinum toxins: time to end the confusion.
Brin MF; Tan K; Gallagher C
J Cosmet Laser Ther; 2009 Sep; 11(3):180-1. PubMed ID: 19626521
[No Abstract] [Full Text] [Related]
10. Long-term safety of botulinum toxin type A.
Naumann M; Moore AP
Mov Disord; 2003 Sep; 18(9):1080-1. PubMed ID: 14502686
[No Abstract] [Full Text] [Related]
11. Sensory profiles: A new strategy for selecting patients in treatment trials for neuropathic pain.
Cruccu G; Truini A
Pain; 2009 Nov; 146(1-2):5-6. PubMed ID: 19625126
[No Abstract] [Full Text] [Related]
12. [Botulinum toxin type A and cholinergic system].
Bach-Rojecky L; Relja M; Filipović B; Lacković Z
Lijec Vjesn; 2007 Dec; 129(12):407-14. PubMed ID: 18383744
[TBL] [Abstract][Full Text] [Related]
13. Central origin of the antinociceptive action of botulinum toxin type A.
Bach-Rojecky L; Lacković Z
Pharmacol Biochem Behav; 2009 Dec; 94(2):234-8. PubMed ID: 19732788
[TBL] [Abstract][Full Text] [Related]
14. An open study of botulinum-A toxin treatment of trigeminal neuralgia.
Voller B; Sycha T; Gustorff B; Kranz G; Auff E
Neurology; 2006 May; 66(9):1458-9; author reply 1458-9. PubMed ID: 16685761
[No Abstract] [Full Text] [Related]
15. An open study of botulinum-A toxin treatment of trigeminal neuralgia.
Brenner SR
Neurology; 2006 May; 66(9):1458-9; author reply 1458-9. PubMed ID: 16682696
[No Abstract] [Full Text] [Related]
16. Microneurography: an opportunity for translational drug development in neuropathic pain.
Serra J
Neurosci Lett; 2010 Feb; 470(3):155-7. PubMed ID: 20045040
[No Abstract] [Full Text] [Related]
17. What is analgesia?
Dews PB
Adv Biochem Psychopharmacol; 1973; 8(0):235-43. PubMed ID: 4369445
[No Abstract] [Full Text] [Related]
18. Retargeted clostridial endopeptidases: inhibition of nociceptive neurotransmitter release in vitro, and antinociceptive activity in in vivo models of pain.
Chaddock JA; Purkiss JR; Alexander FC; Doward S; Fooks SJ; Friis LM; Hall YH; Kirby ER; Leeds N; Moulsdale HJ; Dickenson A; Green GM; Rahman W; Suzuki R; Duggan MJ; Quinn CP; Shone CC; Foster KA
Mov Disord; 2004 Mar; 19 Suppl 8():S42-7. PubMed ID: 15027053
[TBL] [Abstract][Full Text] [Related]
19. What can we learn from failed neuropathic pain trials?
Polydefkis M; Raja SN
Neurology; 2008 Jan; 70(4):250-1. PubMed ID: 18209199
[No Abstract] [Full Text] [Related]
20. Botulinum toxin for hyperhidrosis: an important tool but not the ultimate cure.
Bechara FG; Sand M; Altmeyer P; Schmidt J
Dermatol Surg; 2008 Jun; 34(6):854-5; author reply 855-6. PubMed ID: 18363727
[No Abstract] [Full Text] [Related]
[Next] [New Search]
